scispace - formally typeset
T

Tomas B. Walden

Researcher at Stockholm University

Publications -  9
Citations -  2671

Tomas B. Walden is an academic researcher from Stockholm University. The author has contributed to research in topics: Adipose tissue & PRDM16. The author has an hindex of 6, co-authored 9 publications receiving 2470 citations. Previous affiliations of Tomas B. Walden include Heriot-Watt University.

Papers
More filters
Journal ArticleDOI

Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes

TL;DR: It is reported here that chronic treatment with the peroxisome proliferator-activated receptor γ agonist rosiglitazone promotes not only the expression of PGC-1α and mitochondriogenesis in these cells but also a norepinephrine-augmentable UCP1 gene expression in a significant subset of the cells, providing these cells with a genuine thermogenic capacity.
Journal ArticleDOI

Recruited vs. nonrecruited molecular signatures of brown, “brite,” and white adipose tissues

TL;DR: The effect of physiologically induced recruitment of thermogenic function (cold acclimation) on the expression pattern of the genes was quantified; in general, the depot pattern dominated over the recruitment effects.
Journal ArticleDOI

Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes.

TL;DR: In this paper, the miRNAs are differentially expressed in white and brown primary cell cultures for differential expression of microRNAs, showing that brown and myocytes derive from a common cell lineage that specifies energy-dissipating cells.
Journal ArticleDOI

Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?

TL;DR: Regulation of the PINK1 locus, previously linked to neurodegen‐erative disease, is altered in obesity, type 2 diabetes and inactivity, while the combination of RNAi experiments and clinical data suggests a role for Pink1 in cell energetics rather than in mitochondrial biogenesis.